X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (84) 84
performing operations (63) 63
transporting (63) 63
lining machines (57) 57
printing (57) 57
stamps (57) 57
typewriters (57) 57
colour printing (54) 54
printing, duplicating, marking, or copying processes (54) 54
apoptosis (48) 48
animals (45) 45
blasting (37) 37
heating (37) 37
lighting (37) 37
mechanical engineering (37) 37
weapons (37) 37
mice (35) 35
oncology (34) 34
chemistry (31) 31
male (31) 31
metallurgy (31) 31
female (29) 29
physics (26) 26
adhesives (25) 25
dyes (25) 25
miscellaneous applications of materials (25) 25
miscellaneous compositions (25) 25
natural resins (25) 25
paints (25) 25
polishes (25) 25
chemical paint or ink removers (24) 24
coating compositions, e.g. paints, varnishes orlacquers (24) 24
correcting fluids (24) 24
filling pastes (24) 24
index medicus (24) 24
inks (24) 24
pastes or solids for colouring or printing (24) 24
use of materials therefor (24) 24
woodstains (24) 24
correction of typographical errors (23) 23
i.e. mechanisms printing otherwise than from a forme (23) 23
selective printing mechanisms (23) 23
combustion engines (21) 21
expression (21) 21
hot-gas or combustion-product engine plants (21) 21
proto-oncogene proteins c-bcl-2 - metabolism (21) 21
electricity (20) 20
apoptosis - drug effects (19) 19
cancer (17) 17
tumor cells, cultured (17) 17
biochemistry & molecular biology (16) 16
combustion engines in general (15) 15
internal-combustion piston engines (15) 15
aged (14) 14
antineoplastic agents - pharmacology (14) 14
bcl-2 (14) 14
middle aged (14) 14
molecular sequence data (14) 14
cell biology (13) 13
cell line (13) 13
proto-oncogene proteins c-bcl-2 - antagonists & inhibitors (13) 13
arrangements of sealings in combustion engines (12) 12
article (12) 12
cylinders, pistons or casings, for combustion engines (12) 12
proteins (12) 12
adult (11) 11
caspases - metabolism (11) 11
hematology (11) 11
myeloid cell leukemia sequence 1 protein (11) 11
non-portable lighting devices (11) 11
systems thereof (11) 11
vehicle lighting devices specially adapted for vehicleexteriors (11) 11
albums (10) 10
base sequence (10) 10
bcl-2-associated x protein (10) 10
book covers (10) 10
bookbinding (10) 10
books (10) 10
calculating (10) 10
cell line, tumor (10) 10
computing (10) 10
counting (10) 10
devices for use therewith and not otherwise providedfor (10) 10
electric digital data processing (10) 10
files (10) 10
immunohistochemical analysis (10) 10
leukemia, lymphocytic, chronic, b-cell - pathology (10) 10
loose leaves (10) 10
models, molecular (10) 10
movable-strip writing or reading apparatus (10) 10
printed matter characterised by identification or securityfeatures (10) 10
printed matter of special format or style nototherwise provided for (10) 10
special printed matter (10) 10
aged, 80 and over (9) 9
amino acid sequence (9) 9
basic electric elements (9) 9
cells (9) 9
death (9) 9
electric communication technique (9) 9
engine plants in general (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A10913 - A10913
IntroductionTolvaptan is a vasopressin type 2 receptor antagonist used in heart failure (HF) with refractory diuretic resistance. However, since tolvaptan is... 
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A10921 - A10921
IntroductionAlthough silent brain infarction (SBI) is an independent risk factor for subsequent symptomatic stroke and dementia in patients with nonvalvular... 
Journal Article
IJC Heart & Vasculature, ISSN 2352-9067, 12/2018, Volume 21, pp. 69 - 73
Tolvaptan is a vasopressin type 2 receptor antagonist used in heart failure (HF) with refractory diuretic resistance. However, since tolvaptan is also... 
Heart failure | Tolvaptan | Drug responder | Echocardiography | Right ventricle
Journal Article
Chemistry of Materials, ISSN 0897-4756, 2016, Volume 28, Issue 2, pp. 416 - 419
Journal Article
Journal Article
2012, ISBN 364216482X, Volume 5, 4
Reference
Heart and Vessels, ISSN 0910-8327, 11/2018, Volume 33, Issue 11, pp. 1325 - 1333
Journal Article
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 07/2002, Volume 1, Issue 9, pp. 667 - 677
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 17915 - 7
D-amino acids (D-AAs) have various biological activities, such as activation of N-methyl-D-aspartic acid (NMDA) receptor as a co-agonist by D-Ser. Since... 
GLYCINE | ACT | D-SERINE | SEQUENCES | MULTIDISCIPLINARY SCIENCES | GUT MICROBIOTA | BRAIN | D-ALANINE | Glutamic acid receptors (ionotropic) | N-Methyl-D-aspartic acid receptors | Amino acids | Mass spectroscopy | Liquid chromatography | Glutamic acid receptors | D-Amino acids | Microbiota | Intestine | Bacteria | Aspartic acid | Intestinal microflora | D-aspartic acid
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, p. e24102
As single agents, ABT-263 and ABT-737 (ABT), molecular antagonists of the Bcl-2 family, bind tightly to Bcl-2, Bcl-xL and Bcl-w, but not to Mcl-1, and induce... 
CHRONIC MYELOGENOUS LEUKEMIA | CYTOGENETIC RESPONSES | MITOCHONDRIAL PERMEABILITY TRANSITION | PROSTATE-CANCER | IN-VIVO | BIOLOGY | GLYCOLYSIS INHIBITION | CYTOCHROME-C RELEASE | BH3 MIMETIC ABT-737 | ONCOGENE ADDICTION | MEMBRANE PERMEABILIZATION | Neoplasms - metabolism | Piperazines - administration & dosage | Apoptosis - drug effects | Humans | Male | Dose-Response Relationship, Drug | Proto-Oncogene Proteins c-bcl-2 - metabolism | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | Deoxyglucose - pharmacology | Aniline Compounds - administration & dosage | Aniline Compounds - pharmacology | Cytochromes c - metabolism | Nitrophenols - administration & dosage | Mitochondria - metabolism | Mitochondria - drug effects | Sulfonamides - pharmacology | Piperazines - pharmacology | Blotting, Western | Hep G2 Cells | Mice, Knockout | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Myeloid Cell Leukemia Sequence 1 Protein | Biphenyl Compounds - administration & dosage | Survival Analysis | Cell Line, Tumor | Deoxyglucose - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Mice | HeLa Cells | Neoplasms - pathology | Sulfonamides - administration & dosage | Cytochrome c | Glucose metabolism | Cancer cells | Glucose | Prostate cancer | Dextrose | Cancer | Apoptosis | Cytochrome | Neurosciences | Bax protein | Bcl-2 protein | Leukemia | Antagonists | Genomes | Kinases | Phosphatase | Cancer therapies | Deoxyglucose | Proteins | Mitochondria | Bcl-x protein | Animal tissues | Xenografts | Glucose transporter | Medical research | Melanoma | Addictions | Mcl-1 protein | Cell death | Glycolysis | Prostate | Transporter | Tumors
Journal Article
Oncogene, ISSN 0950-9232, 05/2002, Volume 21, Issue 21, pp. 3459 - 3474
Ever since the discovery of Bcl-2 and the elucidation of its role in apoptosis, tremendous interest has arisen in prospects for triggering suicide of malignant... 
Malignancy | Programmed cell death | Apoptosis | Protein Biosynthesis | Models, Biological | Humans | Gene Expression Regulation, Neoplastic | Clinical Trials as Topic | Hematologic Neoplasms - genetics | Hematologic Neoplasms - metabolism
Journal Article